OMEROS CORP Depreciation
OMEROS CORP (OMER) reported Depreciation of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- OMEROS CORP depreciation for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- OMEROS CORP depreciation for the quarter ending 2026-03-31 was $200.00K, a 33.33% decline year-over-year.
- OMEROS CORP depreciation for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- OMEROS CORP depreciation for the quarter ending 2025-06-30 was $200.00K, a 0.00% change year-over-year.
- OMEROS CORP depreciation for fiscal 2014 was $326.00K, a 7.95% increase from fiscal 2013.
- OMEROS CORP depreciation for fiscal 2013 was $302.00K, a 5.63% decline from fiscal 2012.
- OMEROS CORP depreciation for fiscal 2012 was $320.00K, a 26.44% decline from fiscal 2011.
- OMEROS CORP depreciation for fiscal 2011 was $435.00K, a 7.84% decline from fiscal 2010.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-12 | $400.00K 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2026-08-12 | $700.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-12 | $400.00K 10-Q · filed 2026-08-12 | $500.00K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-13 | ||||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2025-11-13 | $600.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-14 | $400.00K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-15 | ||||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-13 | $500.00K derived: sum of 2 quarters · filed 2024-11-13 | $700.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-07 | $500.00K 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-15 | ||||
| 2014-12-31 | $326.00K 10-K · filed 2015-03-16 | ||||
| 2013-12-31 | $302.00K 10-K · filed 2015-03-16 | ||||
| 2012-12-31 | $320.00K 10-K · filed 2015-03-16 | ||||
| 2011-12-31 | $435.00K 10-K · filed 2014-03-13 | ||||
| 2010-12-31 | $472.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |